NT5DC1/2 DNA methylation levels in tumor tissue were lower than those in normal tissue, while the DNA methylation levels of NT5DC3 were significantly increased in tumor tissue, suggesting that DNA methylation-targeting drugs may have applications in cancer treatment 36 as they implicate epigenetic regulation in the biological process of PAAD induced by the NT5DC family. Here, NT5DC3 is linked to neoplasm.